banner


September 27, 2006

Drug Discovery and Development ProgramFaculty Talks SpeakersPoster Presentation
Photo Gallery


RD8_home
Global Health and Infectious Disease
Cancer Research

Translational Research: Applying Discovery
Cardiovascular Disease, Obesity & DiabetesInfectious Disease & Pathogens

About Research Days




About the Speakers

 

William Bachovchin, PhD: Professor of Biochemistry and Director of Tufts Biological NMR Center at the Sackler School of Graduate Biomedical Sciences, Tufts University. His current research focuses on the structure, mechanism of action, and biological functions of proteinases, and drug design and discovery.

Jeffrey Blumberg, PhD: Professor of Nutrition Science and Policy and Director of the Antioxidants Research Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. His current research focuses on the synergy between antioxidant phytochemicals and their impact on biomarkers of chronic disease.

John Castellot, PhD: Professor and Director of the Cell, molecular, and Developmental Biology Graduate Program, Department of Anatomy and Cellular Biology at the Sackler
School of Graduate Biomedical Sciences, Tufts University.
Current research focuses on mechanisms regulating proliferation and function of smooth muscle cells in normal and disease states.

Marc D’Alarcao, PhD: Associate Professor of Chemistry in the Michael Chemistry Laboratory at Tufts University, School of Arts and Sciences. His current research focuses on the use of synthetic organic chemistry, especially of inositol-containing carbohydrates to shed light on questions in biology and medicine.

Alice Gottlieb, MD, PhD: Professor and Chair of the Department of Dermatology at Tufts–New England Medical Center. Her research involves developing better treatments for psoriasis and psoriatic arthritis.

David J. Greenblatt, MD: Professor and Chair of the Department of Pharmacology and Experimental Therapeutics at the Sackler School of Graduate Biomedical Sciences, Tufts University. Current research focuses on the events between entry of a drug into the body and its ultimate interaction with a specific receptor site.

Ira Herman, PhD: Professor of Physiology and Director of the Tufts Center for Innovations in Wound Healing Research (TIWR) at the Sackler School of Graduate Biomedical Sciences at Tufts University. His current research focuses on revealing the molecular and cellular mechanisms controlling cell shape and migration during developmental and disease-associated processes, including cell division, angiogenesis and wound healing.

Daniel Jay, PhD: Professor of Physiology at the Department of Physiology at the Sackler School of Graduate Biomedical Sciences, Tufts University. He pioneered CALI, laser inactivation technology to knock down protein function in cells and tissue.  His current research focuses on identifying proteins required for breast cancer metastasis and brain tumor dispersal.

Kenneth Kaitin, PhD: Director of the Tufts Center for the Study of Drug Development and Research Associate Professor of Medicine at the Tufts University School of Medicine. His current research focuses on the factors that contribute to the slow pace and high cost of pharmaceutical R&D and the impact of regulatory and legislative initiatives to speed new drug development and review.

Alan Kopin, MD: Professor of Medicine, Molecular Cardiology, Research Institute at Tufts-New England Medical Center. Tufts University Sackler School appointments, Department of Genetics, Neuroscience, Pharmacology and Experimental Therapeutics. His current research interests are focused on molecular endocrinology with an emphasis on G protein-coupled receptors (GPCRs).

Charlotte Kuperwasser, PhD: Assistant Professor, Department of Anatomy and Cellular Biology at the Sackler School of Graduate Biomedical Sciences, Tufts University. Current research focuses on understanding the various aspects of normal and carcinogenic breast development, with the emphasis on stromal-epithelial interactions involved during progression and metastasis.

John Kyriakis, PhD: Researcher, Molecular Cardiology Research Institute,  and Professor of Medicine, Department of Biochemisty at Tufts–New England Medical Center. Current research focuses on signal transduction pathways recruited by proinflammatory cytokines and growth factors, and how these pathways affect inflammation, cardiac pathology and cell proliferation.

Joseph Lau, MD: Professor of Medicine, Department of Clinical Research at the Sackler School of Graduate Biomedical Sciences, Tufts University. Current research focuses on developing reliable and efficient methods and tools to conduct meta-analyses and in understanding the impact of factors that may contribute to differences of results in clinical studies.

Andrew Leger, PhD: Post-Doctoral Fellow, member of Dr. Athan Kuliopulos’ Lab, located within the Molecular Oncology Research Institute of Tufts–New England Medical Center. Current research focuses on the role of protease-activated receptors (PARs) in cardiovascular diseases and the inhibition of PARs using a novel class of cell-penetrating GPCR inhibitors termed Pepducins.

Mohsen Meydani, DVM, PhD: Senior Scientist and Director of the Vascular Biology Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. Current research focuses on the role of dietary antioxidants, lipids and oxidative stress on molecular mechanisms of immune/endothelial cells interaction in atherogenesis and angiogenesis.

George Saperstein, DVM: Professor and Assistant Dean for Research in the Department of Environmental and Population Health, International Veterinary Medicine at the Cummings School of Veterinary Medicine at Tufts University. Current research focuses on cross-border livestock disease control in the Middle East, preservation of germplasm from endangered breeds of livestock, antibiotic susceptibility diagnostics, congenital and hereditary diseases of large animals, and staphylococcal mastitis in cows and goats.

Harry Selker, MD, MSPH: Professor of Medicine and Executive Director of the Tufts–New England Medical Center Institute for Clinical Research and Health Policy Studies and Director of the Tufts Sackler School Graduate Program in Clinical Research. Current research focuses on mathematical modeling of medical outcomes, clinical trial design, and emergency cardiac care and treatments.

Charles Shoemaker, PhD: Professor, Department of Biomedical Sciences, Division of Infectious Diseases at the Cummings School of Veterinary Medicine at Tufts University. His current research focuses on the development of botulism therapeutics and the development of therapeutics and vaccines for parasitic worm infections.

 



Tufts University, Office of the Vice Provost
Health Sciences Campus: (617) 636-6550
Medford Campus: (617) 627-3417
Copyright 2009 Tufts University. All Rights Reserved.
Please send questions/comments about this site to Webmaster.